Analyst Price Targets — APLS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 28, 2026 11:16 am | Joseph Stringer | Needham | $83.00 | $41.03 | StreetInsider | Needham Reiterates Buy Rating on Apellis Pharmaceuticals (APLS) |
| April 17, 2026 9:18 am | — | Wells Fargo | $41.00 | $40.87 | TheFly | Apellis downgraded to Equal Weight from Overweight at Wells Fargo |
| January 27, 2026 9:23 pm | — | Barclays | $24.00 | $21.81 | TheFly | Apellis initiated with an Equal Weight at Barclays |
| January 20, 2026 11:06 am | — | Wells Fargo | $26.00 | $19.94 | TheFly | Apellis price target lowered to $26 from $29 at Wells Fargo |
| January 13, 2026 12:54 pm | — | Cantor Fitzgerald | $35.00 | $23.20 | TheFly | Apellis price target lowered to $35 from $39 at Cantor Fitzgerald |
| January 12, 2026 6:45 pm | — | Goldman Sachs | $19.00 | $23.20 | StreetInsider | Goldman Sachs on Apellis Pharmaceuticals (APLS): 'we see limited near-term growth levers' |
| December 19, 2025 12:47 pm | — | Stifel Nicolaus | $48.00 | $24.48 | TheFly | Apellis price target lowered to $48 from $55 at Stifel |
| November 3, 2025 11:36 am | Graig Suvannavejh | Mizuho Securities | $19.00 | $21.47 | StreetInsider | Apellis Pharmaceuticals (APLS) PT Lowered to $19 at Mizuho |
| October 31, 2025 11:25 am | — | Robert W. Baird | $52.00 | $20.73 | TheFly | Apellis price target raised to $52 from $50 at Baird |
| October 31, 2025 10:05 am | — | H.C. Wainwright | $45.00 | $20.73 | TheFly | Apellis price target lowered to $45 from $57 at H.C. Wainwright |
Latest News for APLS
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout
Biogen said on Friday it had either paused or discontinued funding for most of Apellis Pharmaceuticals' research programs as it integrates the rare-disease drugs specialist it purchased for $5.6 billion earlier this year.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for APLS.
U.S. House Trading
No House trades found for APLS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.